Micro Market Research
+1-888-502-0539
US/CAN Toll Free

You are here :   Home     Healthcare     infertility Treatment     Global Wound Management Market     Global Traditional Wound Care Market     Global Wound Closure Market     Hemostats    
Real Time Market Research & Industry Analysis - MicroMarketMonitor

Asia Pacific Hemostats Market, By Type (Thrombin-Based, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, And Collagen Based Hemostats), - Forecast To 2021

  • Report Code: HE 1002
  • Publish Date: Upcoming
  
Description
Table of Contents
Customer Intelligence
Summary
Inquiry Before Buying Ask for Discount

When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding. The usage of hemostats must be quick, localized, and carefully regulated. Although, the usage of hemostats is not required until and unless the bleeding is heavy or the patient is suffering from congenital diseases or trauma defects.

 

The purpose of this report is to cover the description, definition and forecast of the Asia-pacific Hemostats market. It involves deep dive analysis of market segmentation, which comprises of products type. The Asia-pacific Hemostats market is expected to reach USD 455.9 million by 2021 from USD 290.3 million in 2015, at a CAGR of 7.8% from 2016 to 2021. In 2015, Japan dominated the Hemostats market registering around 32.6% market share, and the region’s market is expected to grow at a CAGR of 7.8% during the forecast period. Factors such as increasing surgery procedures, increasing number of insurance providers are propelling the growth of this market.

 

By type, the Asia-pacific Hemostats market is divided into thrombin based hemostats, oxidized regenerated cellulose based hemostats, gelatin based hemostats, combination hemostats, and collagen based hemostats. The thrombin based hemostats accounted for the largest share of 29.4% of the Asia-pacific Hemostats market in 2015.

 

In-depth market share analysis, by revenue, of the top companies is also included in the report. These numbers are arrived at, based on key facts, annual financial information from SEC filings, annual reports, and interviews with industry experts and key opinion leaders, such as CEOs, directors, and marketing executives.

 

The major players in this market include Johnson & Johnson Services, Inc. (U.S.). C. R. Bard, Inc. (U.S.), Baxter (U.S.), B Braun Melsungen AG (Germany), Pfizer Inc. (U.S.), Vascular Solutions, Inc. (U.S.), Gelita Medical GmbH (Germany), Equimedical (Netherlands), Integra Lifesciences Holdings Corporation (U.S.), Z-Medica, LLC (U.S.), and Marine Polymer Technologies, Inc. (U.S.). These companies have adopted various strategies, such as mergers & acquisitions and partnerships, among others, to achieve growth in the Asia-pacific Hemostats market.

 

Scope of the Report:

This report categorizes the Asia-Pacific market for Hemostats on the basis of type, application, end-user, and region.

 

Market Segmentation, by Type:

Based on type, the Asia-pacific Hemostats market is segmented into Thrombin Based Hemostats, Combination Hemostats, Oxidized Regenerated Cellulose Based Hemostats, Gelatin Based Hemostats, and Collagen Based Hemostats

 

Market Segmentation, by Geography:

The regional analysis covers Japan, China, India, Republic of Korea, Australia and New Zealand.

 

Target Audience:

  • Biosurgerical Product Manufacturers
  • Associations and International Bodies
  • Medical Device Companies
  • Research and Consulting Firms
  • Vendors and Service Providers
  • Regulatory Authorities (such as FDA and insurance providers)

 

Customization Options:

  • Usage pattern (in-depth trend analysis) of products (segment-wise)
  • Product matrix, which gives a detailed comparison of product portfolio of each company mapped at the country and subsegment level
  • End-user adoption rate analysis of products (segment and country-wise)
  • Comprehensive coverage of product approvals, volume data, pipeline products, and product recalls
  • Brand/product perception matrix


1 Introduction
1.1 Objectives Of The Study
1.2 Market Segmentation & Coverage
1.3 Stakeholders
2 Research Methodology
2.1 Integrated Ecosystem Of Hemostats Market
2.2 Arriving At The Hemostats Market Size
2.2.1 Top-Down Approach
2.2.2 Bottom-Up Approach
2.2.3 Demand Side Approach
2.2.4 Macro Indicator-Based Approach
3 Market Overview
3.1 Introduction
3.2 Asia Hemostats Market: Comparison With Parent Market
3.3 Market Drivers And Inhibitors
3.4 Key Market Dynamics
3.5 Demand Side Analysis
3.6 Vendor Side Analysis
4 Competitive Landscape
4.1 Hemostats Market: Company Share Analysis
4.2 Company Presence In Hemostats Market, By Type
5 Hemostats Market, By Company
6 APPENDIX

Please fill in the form below to receive a free copy of the Summary of this Report
















Asia Pacific Hemostats Market, By Type (Thrombin-Based, Oxidized Regenerated Cellulose Based Hemostats, Combination Hemostats, Gelatin Based Hemostats, And Collagen Based Hemostats), - Forecast To 2021

* Enter the text from the image to the text box :

refresh captcha
Custom Market Research Services
We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.micromarketmonitor.com/custom-research-services.html to specify your custom Research Requirement
PRODUCT TITLE PUBLISHED
North American Wound Closure Market North American Wound Closure Market
The North American Wound Closure Market was valued at $1.2 billion in 2013 and is expected to reach $1.4 billion by 2018, at a CAGR of 2.0%. The report “North American Wound closure Market forecast, 2012-2018” analyzes the market of Wound Closure by 3 segments such as Sutures, Staples and Staplers, Tissue adhesives, Sealants and glues. The main companies operating in Wound closure market and extensively covered in this report are Smith & Nephew, 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien and Molnlycke healthcare.
Upcoming
European Wound Closure Market European Wound Closure Market
The European Wound Closure Market was valued at $431 million in 2013 and is expected to reach $473 million by 2018, at a CAGR of 2.1%. The report “European Wound closure Market forecast, 2012-2018” analyzes the market of Wound Closure by 3 segments such as Sutures, Staples and Staplers, Tissue adhesives, Sealants and glues. The main companies operating in this market and extensively covered in this report are Smith & Nephew, 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien and Molnlycke healthcare.
Upcoming
Asian Wound Closure Market Asian Wound Closure Market
The Asian Wound Closure Market was valued at $262 million in 2013 and is expected to reach $294 million by 2018, at a CAGR of 2.6%. The report “Asian Wound closure Market forecast, 2012-2018” analyzes the market of Wound Closure by 3 segments such as Sutures, Staples and Staplers, Tissue adhesives, Sealants and glues. The main companies operating in this market and extensively covered in this report are Smith & Nephew, 3M healthcare, Johnson and Johnson, Derma Sciences, Covidien and Molnlycke healthcare.
Upcoming
of items
reports | Show
Connect With Us
US/CAN : +1-888-502-0539